These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16552064)

  • 21. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2003 Feb; 71(2):733-8. PubMed ID: 12540552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against intranasal infection of mice with Bordetella pertussis.
    Robinson A; Ashworth LA; Baskerville A; Irons LI
    Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroid Suppressor Cells Compromise Neonatal Immune Response against
    Dunsmore G; Bozorgmehr N; Delyea C; Koleva P; Namdar A; Elahi S
    J Immunol; 2017 Sep; 199(6):2081-2095. PubMed ID: 28779022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
    Geurtsen J; Fae KC; van den Dobbelsteen GP
    Expert Rev Vaccines; 2014 Oct; 13(10):1229-40. PubMed ID: 25081731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.
    Nascimento IP; Dias WO; Quintilio W; Hsu T; Jacobs WR; Leite LC
    Vaccine; 2009 Dec; 27(52):7346-51. PubMed ID: 19782111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to Bordetella pertussis.
    Mills KH
    Microbes Infect; 2001 Jul; 3(8):655-77. PubMed ID: 11445452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
    Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
    Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
    Lim A; Ng JK; Locht C; Alonso S
    Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on pertussis in children.
    Heininger U
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):163-73. PubMed ID: 20109046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-FIM and Anti-FHA Antibodies Inhibit
    Yougbare I; McTague A; He L; Choy CH; Su J; Gajewska B; Azizi A
    Front Immunol; 2020; 11():605273. PubMed ID: 33384692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD11c+CD8alpha+ dendritic cells promote protective immunity to respiratory infection with Bordetella pertussis.
    Dunne PJ; Moran B; Cummins RC; Mills KH
    J Immunol; 2009 Jul; 183(1):400-10. PubMed ID: 19542451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity to pertussis. Not all virulence factors are protective antigens.
    Robbins JB; Schneerson R; Bryla DA; Trollfors B; Taranger J; Lagergård T
    Adv Exp Med Biol; 1998; 452():207-18. PubMed ID: 9889975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of beta-defensins pBD-1 and pBD-2 along the small intestinal tract of the pig: lack of upregulation in vivo upon Salmonella typhimurium infection.
    Veldhuizen EJ; van Dijk A; Tersteeg MH; Kalkhove SI; van der Meulen J; Niewold TA; Haagsman HP
    Mol Immunol; 2007 Jan; 44(4):276-83. PubMed ID: 16620987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.